Remdesivir has come as a hopeful word for the world standing in the face of the terrible crisis of Corona. The drug Remdesivir of the US pharmaceutical company Gilead Sciences Inc seen as an alternative treatment for corona infection. On Wednesday, on behalf of Gilead, it has been said that the third phase of Remdesivir trial has also yielded positive results. Significantly, people were eagerly waiting for the results of the third phase of this medicine.
How have the tests done
Remdesivir has also been performed on in vitro (test tubes) and in vivo (body tests) test animals. Testing of this drug on MERS and SARS in animals has been successful. The coronavirus is also part of the family of these diseases. The company says that only after testing on animals, we came to know that the effect of this drug can do in the treatment of Corona.
Also Read: Irrfan Khan does not want to become an actor he wants to become a cricketer
The company has said that on March 22, there has been a demand to send Remdesivir for compassionate use. Compassionate-use is said to be the treatment that doctors use, but it has not completely tested for the disease. Doctors use it when there is no option of therapy during treatment.
Remdesivir has been used to treat Corona under the compassionate-use programme. It was done on those patients who were not being treated with authorized medicines. The company says that after this there was a flood of demand for this medicine under compassionate use.
Single Arm Trial Results
orphan drug status
On March 23, Remdesivir was given orphan drug status by the US Department of Food and Drug Administration. This status is given to medicines which show the potential ability to cure a disease. They are called orphan or orphans because their commercial production is halted and government support is needed for this. Significantly, Remdesivir is used in the treatment of the Ebola epidemic. Because of this status, the company Gilead Sciences will get many concessions. Such as the monopoly of making medicine in the market for seven years. Also, there is an exemption in tax which can be used to develop medicine.
Third stage trial
The price will matter for India
The drug Remdesivir was discovered in the mid-2010s. Initially, tests done on animals had proved that this drug would work accurately in the treatment of Ebola. But during the third phase of a major trial in the Democratic Republic of Congo, it was found out that this drug is not that effective in curing Ebola completely. But now due to Corona’s meeting with Sars and Mars, it is believed that this drug will prove effective in the treatment of Corona. Researchers believe that after the Phase III trial, the US Department of Food and Drug Administration will be quick to approve the drug. As it did in 1987 in the case of azidothymidine- AZT, a drug made with HIV / AIDS. But now everything depends on the results of the third phase.
